AstraZeneca’s ‘Reframing COPD’ Regional Forum aims to provide local leaders in respiratory medicine with an opportunity to share best-practices and discuss patient pathways specific to regional settings. Through interactive discussions and workshops; some of the most important topics relevant to COPD management within secondary care will be explored; including addressing cardiopulmonary risk and premature death; implementing guidance into practice; and the importance of timely treatment optimisation for patients with COPD. This meeting will be an opportunity to reflect on incremental changes that can collectively drive practice change to enable meaningful advancements in COPD management; reframing how care is delivered.